305384-32-1 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 5 carbon (C), 11 hydrogen (H), 1 nitrogen (N), and 2 oxygen (O) atoms.
Explanation
This is the systematic name of the compound, which provides information about its structure and stereochemistry.
Explanation
This is an alternative name for the compound, which describes its functional groups and the positions of these groups in the molecule.
Explanation
The compound is derived from cyclopentanediol, which is a five-membered ring with two hydroxyl (OH) groups attached to adjacent carbon atoms.
Explanation
The compound contains an amino group (-NH2) and a hydroxymethyl group (-CH2OH), which are important for its reactivity and potential applications.
Explanation
The compound is a stereoisomer, which means it has the same molecular formula but a different arrangement of atoms in space. The (1S,2S,3R,5R)configuration indicates the specific arrangement of the chiral centers in the molecule.
Explanation
The compound has potential applications in various industries, including the development of new drugs, agricultural chemicals, and synthetic materials.
Explanation
Research is still being conducted to better understand the properties of this compound and to explore its potential uses in various fields.
Derivative
Cyclopentanediol
Functional Groups
Amino group, Hydroxymethyl group
Stereoisomer
(1S,2S,3R,5R)configuration
Applications
Pharmaceutical, Agricultural, Synthetic Materials
Ongoing Research
Properties and Potential Uses
Check Digit Verification of cas no
The CAS Registry Mumber 305384-32-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,5,3,8 and 4 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 305384-32:
(8*3)+(7*0)+(6*5)+(5*3)+(4*8)+(3*4)+(2*3)+(1*2)=121
121 % 10 = 1
So 305384-32-1 is a valid CAS Registry Number.
305384-32-1Relevant articles and documents
COMPOUNDS TARGETING PRMT5
-
, (2021/10/11)
Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
Synthesis of 4a-Carba-d-lyxofuranose Derivatives and Their Evaluation as Inhibitors of GH38 α-Mannosidases
Zaji?ková, Mária,Monco?, Ján,?esták, Sergej,Kóňa, Juraj,Koó?, Miroslav,Bella, Maro?
, p. 1114 - 1124 (2019/01/24)
A synthetic approach to 4a-carba-d-lyxofuranose derivatives starting from d-lyxose is described. The protected 4a-carba-β-d-lyxofuranose was employed as the key intermediate for the synthesis of 4a-carba-d-lyxofuranose derivatives including novel 1-amino-1-deoxy-4a-carba-d-lyxofuranoses. Synthesized 4a-carba-d-lyxofuranoses were evaluated as inhibitors of GH38 α-mannosidases, namely, the Golgi (GMIIb) and lysosomal (LManII) α-mannosidases from Drosophila melanogaster and commercial Jack bean α-mannosidase (JBMan) from Canavalia ensiformis. The biochemical evaluation revealed that only 1-amino-1-deoxy-4a-carba-β-d-lyxofuranose exhibited reasonable inhibitory activity against GMIIb (IC50 = 200 μm). In addition, the results of biological evaluation were discussed by means of molecular modelling.
ENZYMATIC SYNTHESIS OF CARBA-NAD
-
Page/Page column 4, (2012/06/01)
The disclosure concerns the enzymatic synthesis of stable analogues of nicotinamide adenine dinucleotide NAD/NADH and nicotinamide adenine dinucleotide phosphate NADP/NADPH, the so-called “carba-NADs”, i.e. analogues of NAD/NADH or NADP/NADPH, respectively, comprising a carbacyclic sugar instead of ribose.
